|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.50 CNY | -1.86% |
|
+0.54% | +4.99% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 24.7 | +31.03% | 7 | ||||||
| 60.65 | +78.26% | 16 | ||||||
| 4.632 | +49.62% | 15 | ||||||
| 2,976 | +17.42% | 10 | ||||||
| 33.09 | +45.57% | 12 | ||||||
| 122.07 | +27.16% | 9 | ||||||
| 327.88 | +48.67% | 8 | ||||||
| - | - | 1,415 | +189.39% | 1 | ||||
| 47 | +18.9% | 6 | ||||||
| 37.19 | +23.83% | 8 | ||||||
| 86.1 | +40.23% | 10 | ||||||
| 14.86 | +27.35% | 5 | ||||||
| 54.32 | +34.14% | 8 | ||||||
| 1,013.14 | +43.72% | 7 | ||||||
| - | 92.5 | +25.94% | 2 | |||||
| - | 5,100 | +36.55% | 2 | |||||
| Average | 713.07 | +46.11% | 8 | ||||||
| Weighted average by Cap. | 537.89 | +54.65% | 11 |
Select your edition
All financial news and data tailored to specific country editions
